NO160141C - Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte as-triazinderivater. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte as-triazinderivater.

Info

Publication number
NO160141C
NO160141C NO843755A NO843755A NO160141C NO 160141 C NO160141 C NO 160141C NO 843755 A NO843755 A NO 843755A NO 843755 A NO843755 A NO 843755A NO 160141 C NO160141 C NO 160141C
Authority
NO
Norway
Prior art keywords
preparation
triazine derivatives
therapeutic active
analogy procedure
active condensed
Prior art date
Application number
NO843755A
Other languages
English (en)
Other versions
NO160141B (no
NO843755L (no
Inventor
Andras Messmer
Sandor Batori
Gyoergy Hajos
Pal Benko
Eva Furdyga
Lujza Petoecz
Katalin Grasser
Ibolya Kosoczky
Enikoe Kiszelly Szirt
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NO843755L publication Critical patent/NO843755L/no
Publication of NO160141B publication Critical patent/NO160141B/no
Publication of NO160141C publication Critical patent/NO160141C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO843755A 1983-09-20 1984-09-20 Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte as-triazinderivater. NO160141C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU833242A HU190504B (en) 1983-09-20 1983-09-20 Process for preparing condensed as-triazinium-derivatives

Publications (3)

Publication Number Publication Date
NO843755L NO843755L (no) 1985-03-21
NO160141B NO160141B (no) 1988-12-05
NO160141C true NO160141C (no) 1989-03-15

Family

ID=10963273

Family Applications (2)

Application Number Title Priority Date Filing Date
NO843756A NO160997C (no) 1983-09-20 1984-09-20 Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte as-triazinderivater.
NO843755A NO160141C (no) 1983-09-20 1984-09-20 Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte as-triazinderivater.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO843756A NO160997C (no) 1983-09-20 1984-09-20 Analogifremgangsmaate til fremstilling av terapeutisk aktive kondenserte as-triazinderivater.

Country Status (24)

Country Link
US (1) US4602018A (no)
JP (1) JPS6089484A (no)
AT (1) AT390791B (no)
BE (1) BE900598A (no)
BG (4) BG44377A3 (no)
CH (1) CH662116A5 (no)
CS (1) CS259522B2 (no)
DD (1) DD228252A5 (no)
DK (1) DK160095C (no)
ES (6) ES8607952A1 (no)
FI (1) FI80451C (no)
FR (1) FR2552085B1 (no)
GB (1) GB2148885B (no)
GR (1) GR80430B (no)
HU (1) HU190504B (no)
IL (1) IL73011A (no)
IT (1) IT1176744B (no)
NL (1) NL8402891A (no)
NO (2) NO160997C (no)
PL (2) PL144187B1 (no)
PT (1) PT79242B (no)
SE (1) SE456584B (no)
SU (4) SU1447283A3 (no)
YU (1) YU45663B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190505B (en) * 1983-09-20 1986-09-29 Egis Gyogyszergyar,Hu Process for preparing condensed as-triazine-derivatives of twin ion type
HU199464B (en) * 1986-05-06 1990-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing condensed cis-triazine derivatives
HU203099B (en) * 1987-10-02 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing condensed quinolinium- and isoquinolinium derivatives and pharmaceutical compositions containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080192A (en) * 1977-04-14 1978-03-21 E. I. Du Pont De Nemours And Company Substituted bicyclic triazines
HU187305B (en) * 1980-07-18 1985-12-28 Egyt Gyogyszervegyeszeti Gyar Process for producing condensed as-triazine derivatives

Also Published As

Publication number Publication date
ES8801905A1 (es) 1988-03-01
ES8800177A1 (es) 1987-11-01
GB2148885A (en) 1985-06-05
DK160095B (da) 1991-01-28
HU190504B (en) 1986-09-29
ES8800179A1 (es) 1987-11-01
FR2552085B1 (fr) 1987-04-24
YU162284A (en) 1987-10-31
SE456584B (sv) 1988-10-17
ES557301A0 (es) 1987-11-01
FI80451C (fi) 1990-06-11
PL145745B1 (en) 1988-10-31
YU45663B (sh) 1992-07-20
IT1176744B (it) 1987-08-18
ES557298A0 (es) 1988-03-01
IL73011A0 (en) 1984-12-31
SU1414311A3 (ru) 1988-07-30
BG44376A3 (en) 1988-11-15
DK446984D0 (da) 1984-09-19
JPS6089484A (ja) 1985-05-20
ES557299A0 (es) 1988-03-01
AT390791B (de) 1990-06-25
JPH0354951B2 (no) 1991-08-21
PL257819A1 (en) 1987-01-26
ES8607952A1 (es) 1986-06-01
HUT35261A (en) 1985-06-28
NO160141B (no) 1988-12-05
PL257818A1 (en) 1987-01-26
BG44377A3 (en) 1988-11-15
ES8800178A1 (es) 1987-11-01
FI843687A0 (fi) 1984-09-20
CH662116A5 (de) 1987-09-15
PT79242A (en) 1984-10-01
CS259522B2 (en) 1988-10-14
DD228252A5 (de) 1985-10-09
ES8801906A1 (es) 1988-03-01
IT8422749A0 (it) 1984-09-20
IL73011A (en) 1990-03-19
ES557302A0 (es) 1987-11-01
SU1568889A3 (ru) 1990-05-30
NO843756L (no) 1985-03-21
FI80451B (fi) 1990-02-28
PL144187B1 (en) 1988-04-30
SE8404722L (sv) 1985-03-21
FI843687L (fi) 1985-03-21
SU1545942A3 (ru) 1990-02-23
BE900598A (fr) 1985-03-18
FR2552085A1 (fr) 1985-03-22
NO160997B (no) 1989-03-13
DK160095C (da) 1991-06-24
US4602018A (en) 1986-07-22
BG44378A3 (en) 1988-11-15
GB8423797D0 (en) 1984-10-24
PT79242B (en) 1986-08-08
GB2148885B (en) 1987-01-07
NO843755L (no) 1985-03-21
DK446984A (da) 1985-03-21
SE8404722D0 (sv) 1984-09-20
ATA298784A (de) 1989-12-15
ES557300A0 (es) 1987-11-01
ES536104A0 (es) 1986-06-01
NO160997C (no) 1989-06-21
GR80430B (en) 1985-01-23
NL8402891A (nl) 1985-04-16
SU1447283A3 (ru) 1988-12-23
BG43006A3 (en) 1988-03-15

Similar Documents

Publication Publication Date Title
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO163451C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminomethyloxooxazolidinylbenzenderivater.
NO162764C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO164165C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO156864C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO162514C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO161738C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.